Cargando…

A mediation analysis to explain socio‐economic differences in bladder cancer survival

INTRODUCTION: This study aims to disentangle heterogeneity in the survival of bladder cancer (BC) patients of different socioeconomic status (SES) by identifying potential mediators of the relationship. METHODS: The Bladder Cancer Database Sweden (BladderBaSe) was used to select patients diagnosed b...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Beth, Hemelrijck, Mieke V., Gårdmark, Truls, Holmberg, Lars, Kumar, Pardeep, Bellavia, Andrea, Häggström, Christel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571835/
https://www.ncbi.nlm.nih.gov/pubmed/32851811
http://dx.doi.org/10.1002/cam4.3418
_version_ 1783597228959465472
author Russell, Beth
Hemelrijck, Mieke V.
Gårdmark, Truls
Holmberg, Lars
Kumar, Pardeep
Bellavia, Andrea
Häggström, Christel
author_facet Russell, Beth
Hemelrijck, Mieke V.
Gårdmark, Truls
Holmberg, Lars
Kumar, Pardeep
Bellavia, Andrea
Häggström, Christel
author_sort Russell, Beth
collection PubMed
description INTRODUCTION: This study aims to disentangle heterogeneity in the survival of bladder cancer (BC) patients of different socioeconomic status (SES) by identifying potential mediators of the relationship. METHODS: The Bladder Cancer Database Sweden (BladderBaSe) was used to select patients diagnosed between 1997 and 2014 with Tis/Ta‐T4 disease. The education level was used as a proxy for SES. Accelerated failure time models were used to investigate the association between SES and survival. Mediation analysis was used to investigate potential mediators of the association also accounting for interaction. RESULTS: The study included 37 755 patients from the BladderBaSe. Patients diagnosed with both non‐muscle invasive bladder cancer (NMIBC) and muscle‐invasive bladder cancer (MIBC) who had high SES were found to have increased overall and BC‐specific survival, when compared to those with low SES. In the NMIBC patients, Charlson Comorbidity Index was found to mediate this relationship by 10% (percentage of the total effect explained by the mediator) and hospital type by 4%. The time from referral to TURBT was a considerable mediator (14%) in the MIBC patients only. CONCLUSIONS: Mediation analysis suggests that the association between SES and BC survival can be explained by several factors. The mediators identified were not, however, able to fully explain the theoretical causal pathway between SES and survival, therefore, future studies should also include the investigation of other possible mediators to help explain this relationship further. These results highlight the importance of standardization of clinical care across SES groups.
format Online
Article
Text
id pubmed-7571835
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75718352020-10-23 A mediation analysis to explain socio‐economic differences in bladder cancer survival Russell, Beth Hemelrijck, Mieke V. Gårdmark, Truls Holmberg, Lars Kumar, Pardeep Bellavia, Andrea Häggström, Christel Cancer Med Clinical Cancer Research INTRODUCTION: This study aims to disentangle heterogeneity in the survival of bladder cancer (BC) patients of different socioeconomic status (SES) by identifying potential mediators of the relationship. METHODS: The Bladder Cancer Database Sweden (BladderBaSe) was used to select patients diagnosed between 1997 and 2014 with Tis/Ta‐T4 disease. The education level was used as a proxy for SES. Accelerated failure time models were used to investigate the association between SES and survival. Mediation analysis was used to investigate potential mediators of the association also accounting for interaction. RESULTS: The study included 37 755 patients from the BladderBaSe. Patients diagnosed with both non‐muscle invasive bladder cancer (NMIBC) and muscle‐invasive bladder cancer (MIBC) who had high SES were found to have increased overall and BC‐specific survival, when compared to those with low SES. In the NMIBC patients, Charlson Comorbidity Index was found to mediate this relationship by 10% (percentage of the total effect explained by the mediator) and hospital type by 4%. The time from referral to TURBT was a considerable mediator (14%) in the MIBC patients only. CONCLUSIONS: Mediation analysis suggests that the association between SES and BC survival can be explained by several factors. The mediators identified were not, however, able to fully explain the theoretical causal pathway between SES and survival, therefore, future studies should also include the investigation of other possible mediators to help explain this relationship further. These results highlight the importance of standardization of clinical care across SES groups. John Wiley and Sons Inc. 2020-08-26 /pmc/articles/PMC7571835/ /pubmed/32851811 http://dx.doi.org/10.1002/cam4.3418 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Russell, Beth
Hemelrijck, Mieke V.
Gårdmark, Truls
Holmberg, Lars
Kumar, Pardeep
Bellavia, Andrea
Häggström, Christel
A mediation analysis to explain socio‐economic differences in bladder cancer survival
title A mediation analysis to explain socio‐economic differences in bladder cancer survival
title_full A mediation analysis to explain socio‐economic differences in bladder cancer survival
title_fullStr A mediation analysis to explain socio‐economic differences in bladder cancer survival
title_full_unstemmed A mediation analysis to explain socio‐economic differences in bladder cancer survival
title_short A mediation analysis to explain socio‐economic differences in bladder cancer survival
title_sort mediation analysis to explain socio‐economic differences in bladder cancer survival
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571835/
https://www.ncbi.nlm.nih.gov/pubmed/32851811
http://dx.doi.org/10.1002/cam4.3418
work_keys_str_mv AT russellbeth amediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT hemelrijckmiekev amediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT gardmarktruls amediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT holmberglars amediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT kumarpardeep amediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT bellaviaandrea amediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT haggstromchristel amediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT russellbeth mediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT hemelrijckmiekev mediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT gardmarktruls mediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT holmberglars mediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT kumarpardeep mediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT bellaviaandrea mediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival
AT haggstromchristel mediationanalysistoexplainsocioeconomicdifferencesinbladdercancersurvival